Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank57
3Y CAGR-9.9%
5Y CAGR-5.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-9.9%/yr
vs +5.4%/yr prior
5Y CAGR
-5.1%/yr
Recent deceleration
Acceleration
-15.3pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$6.67M+1.2%
2024$6.59M+8.6%
2023$6.07M-33.5%
2022$9.12M+3.5%
2021$8.81M+1.8%
2020$8.65M+16.6%
2019$7.42M+0.6%
2018$7.38M+0.1%
2017$7.37M+23.7%
2016$5.96M-